Literature DB >> 10698032

Role of the vitreous in age-related macular degeneration.

F Ondeş1, G Yilmaz, M A Acar, N Unlü, H Kocaoğlan, A K Arsan.   

Abstract

PURPOSE: To investigate the relationship between posterior vitreous detachment (PVD) and age-related macular degeneration (AMD).
METHODS: The condition of the vitreous was examined by slit-lamp funduscopy and ultrasonography in 93 eyes of 50 patients with AMD (exudative or dry) and 100 eyes of 50 controls.
RESULTS: There was complete PVD in 31 of the 93 eyes (33.3%) of 50 patients with AMD and the posterior vitreous was attached in 62 of these eyes (66.6%). In the control group, in 50 eyes (50%) of 50 subjects there was posterior vitreous detachment. The prevalence of PVD in eyes with macular degeneration was significantly lower (P < .05). There was no statistically significant difference between the exudative and the nonexudative groups in respect to PVD.
CONCLUSIONS: PVD may have a protective role against the development of AMD. Chronic vitreomacular traction and/or continuous exposure to free radicals and cytokines may possibly be one of the causes of AMD in eyes with attached vitreous.

Entities:  

Mesh:

Year:  2000        PMID: 10698032     DOI: 10.1016/s0021-5155(99)00174-4

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  17 in total

1.  High incidence of vitreomacular traction in recurrent choroidal neovascularisation after repeated photodynamic therapy.

Authors:  J C Schmidt; S Mennel; S Hörle; C H Meyer
Journal:  Br J Ophthalmol       Date:  2006-07-19       Impact factor: 4.638

2.  Posterior vitreous detachment with microplasmin alters the retinal penetration of intravitreal bevacizumab (Avastin) in rabbit eyes.

Authors:  David T Goldenberg; Frank J Giblin; Mei Cheng; Shravan K Chintala; Michael T Trese; Kimberly A Drenser; Alan J Ruby
Journal:  Retina       Date:  2011-02       Impact factor: 4.256

3.  Effects of vitreomacular adhesion on ranibizumab treatment in Japanese patients with age-related macular degeneration.

Authors:  Yoko Nomura; Hidenori Takahashi; Xue Tan; Shigeto Fujimura; Ryo Obata; Yasuo Yanagi
Journal:  Jpn J Ophthalmol       Date:  2014-08-06       Impact factor: 2.447

4.  Effect of posterior vitreous detachment on aqueous humor level of vascular endothelial growth factor in exudative age-related macular degeneration patients.

Authors:  Yoko Nomura; Hidenori Takahashi; Xue Tan; Yujiro Fujino; Hidetoshi Kawashima; Yasuo Yanagi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-04-12       Impact factor: 3.117

5.  Evaluation of vitreoretinal interface changes in patients receiving intravitreal anti-VEGF therapy.

Authors:  Vartika Kinra; Satvir Singh; Sumeet Khanduja; Manisha Nada
Journal:  Int Ophthalmol       Date:  2017-03-15       Impact factor: 2.031

6.  The vitreomacular interface in different types of age-related macular degeneration.

Authors:  Mohamed Abd ElMonaem El-Hifnawy; Hisham Ali Ibrahim; Amir Ramadan Gomaa; Mohamed A Elmasry
Journal:  Int J Ophthalmol       Date:  2017-02-18       Impact factor: 1.779

7.  Gas-mediated vitreomacular adhesion release with intravitral ranibizumab injections for exudative age-related macular degeneration.

Authors:  Hae Min Kang; Sung Jun Lee; Chul Gu Kim; Eun Jee Chung; Hyoung Jun Koh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-01-08       Impact factor: 3.117

8.  The role of abnormal vitreomacular adhesion in age-related macular degeneration: spectral optical coherence tomography and surgical results.

Authors:  Francesca Mojana; Lingyun Cheng; Dirk-Uwe G Bartsch; Gabriel A Silva; Igor Kozak; Nitin Nigam; William R Freeman
Journal:  Am J Ophthalmol       Date:  2008-06-06       Impact factor: 5.258

Review 9.  Physiology of vitreous surgery.

Authors:  Einar Stefánsson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-26       Impact factor: 3.117

10.  Posterior vitreous detachment following intravitreal drug injection.

Authors:  Ulrich Geck; Nicole Pustolla; Husnia Baraki; Abed Atili; Nicolas Feltgen; Hans Hoerauf
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-02-05       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.